Crowell Tracker of Court Rulings on Legal Privilege and Artificial Intelligence Tools
Client Alert | 4 min read | 04.23.26
As companies and individuals increasingly embed AI tools in legal practice, courts are grappling with how to treat communications with, and information generated by, these tools. Chief among these questions is whether and in what circumstances attorney-client privilege and work-product protections as they are applied in different jurisdictions extend to AI-generated content or communications with an AI tool.
The applicability of these protections directly affects the ability to keep the information confidential later. Given the rapidly shifting legal landscape, practitioners and their clients should keep apprised of developing case law. Anyone considering using AI tools in connection with litigation, regulated activities, compliance, or other legal activities should consult counsel prior to such use.
We are actively monitoring developments in this area and will continue to update the following case tracker as new decisions become available. Please reach out to our team with questions or requests for specific advice.
Contacts
Insights
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress
Client Alert | 8 min read | 11.16.26
OCC’s AI Examiner Framework: How Banks’ AI Use Can Trigger Legal Liability and Supervisory Exposure
Client Alert | 3 min read | 11.13.26
Massachusetts Trade Secret Preliminary Injunctions: Prove the Harm, Tailor the Relief



